Nov 21, 2024 9:00am EST Avalon GloboCare Regains Compliance with Nasdaq Continued Listing Requirements
Nov 18, 2024 9:00am EST Avalon GloboCare Launches “BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device
Oct 31, 2024 9:00am EDT Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales
Oct 25, 2024 9:00am EDT Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving
Oct 24, 2024 9:00am EDT Avalon GloboCare Announces 1-for-15 Reverse Stock Split as Part of Nasdaq Compliance Plan
Oct 09, 2024 9:00am EDT Avalon GloboCare to Sponsor Keto Pa-LOU-za 2024 Conference and Showcase KetoAir Breathalyzer Device
Aug 14, 2024 8:00am EDT Avalon’s Laboratory Services MSO to Launch Sales of Proprietary FDA-Registered External Male Catheter Device
Jul 31, 2024 8:00am EDT Avalon’s Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction
Jul 18, 2024 9:00am EDT Avalon GloboCare Launches Online Sales of KetoAir Breathalyzer in the U.S. at Ketoair.us
Jun 20, 2024 8:30am EDT Avalon GloboCare Provides Update on the Launch of the KetoAir Breathalyzer at Hack Your Health by KetoCon 2024 Conference